Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Primary Care
•
Preventive Medicine
•
General Primary Care
What specific factors are most important to evaluate when considering low-dose aspirin for primary prevention of ASCVD in patients aged 60 to 69?
Related Questions
How do you counsel patients with metabolic syndrome who decline statin therapy and have low coronary calcium scores regarding their long term CVD risk?
What are some practical ways to incorporate cardiac POCUS in the primary care setting?
How do you decide whether average-risk patients should undergo annual or biennial breast cancer screening?
How do you approach the use of metformin in the management of prediabetes for patients who are neither obese nor have a family history of diabetes?
How do you counsel non-diabetic patients who wish to start metformin to reduce the risk of developing dementia?
Should GLP-1 agonists be used to reduce the risk of dementia in patients with a family history?
How do you counsel patients who express concerns about receiving multiple vaccinations at once versus spacing them out over time?
What is your preferred screening tool for colon cancer in an average-risk patient?
How do you counsel patients on GLP-1 agonists for weight loss who wish to space out their medication or take a "drug holiday" to temporarily increase their appetite?
What are your thoughts on the applicability and utility of the PREVENT equation and how it compares to the PCE for ASCVD risk assessment?
